A detailed history of River Wealth Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, River Wealth Advisors LLC holds 8,294 shares of LLY stock, worth $6.6 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares
8,294
Previous 7,580 9.42%
Holding current value
$6.6 Million
Previous $6.86 Million 7.07%
% of portfolio
0.99%
Previous 0.99%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $551,307 - $685,454
714 Added 9.42%
8,294 $7.35 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $1.45 Million - $1.82 Million
2,003 Added 35.92%
7,580 $6.86 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $2.29 Million - $3.06 Million
3,859 Added 224.62%
5,577 $4.34 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $438,533 - $516,973
835 Added 94.56%
1,718 $1 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $2,608 - $3,595
6 Added 0.68%
883 $474,000
Q2 2023

Aug 09, 2023

BUY
$350.74 - $468.98 $350 - $468
1 Added 0.11%
877 $411,000
Q1 2023

May 11, 2023

BUY
$310.63 - $364.82 $40,071 - $47,061
129 Added 17.27%
876 $300,000
Q4 2022

Feb 10, 2023

BUY
$321.55 - $374.67 $240,197 - $279,878
747 New
747 $273,000
Q1 2019

May 07, 2019

SELL
$111.31 - $131.02 $66,674 - $78,480
-599 Closed
0 $0
Q4 2018

Jan 25, 2019

SELL
$105.9 - $118.64 $60,786 - $68,099
-574 Reduced 48.93%
599 $69,000
Q3 2018

Nov 09, 2018

SELL
$85.86 - $107.31 $31,081 - $38,846
-362 Reduced 23.58%
1,173 $126,000
Q2 2018

Aug 13, 2018

BUY
$75.7 - $86.88 $116,199 - $133,360
1,535 New
1,535 $131,000
Q1 2018

May 02, 2018

SELL
$74.21 - $87.6 $192,871 - $227,672
-2,599 Closed
0 $0
Q4 2017

Feb 09, 2018

SELL
$81.94 - $87.89 $43,428 - $46,581
-530 Reduced 16.94%
2,599 $220,000
Q3 2017

Nov 06, 2017

BUY
$77.07 - $85.54 $241,152 - $267,654
3,129
3,129 $268,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track River Wealth Advisors LLC Portfolio

Follow River Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of River Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on River Wealth Advisors LLC with notifications on news.